Analytical Data
-
Gene name
PEX26
- Application
-
Alternative Names
PEX26M1T; Pex26pM1T; Peroxisome Biogenesis Factor 26; Peroxin-26
-
Species
Human
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q7Z412
-
Expression Region
Met1~Asp305
-
Molecular Weight
61kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PEX26 is a vital component in the realm of peroxisome biogenesis and function, serving as a membrane protein involved in the formation and maintenance of peroxisomes, which are essential organelles responsible for lipid metabolism and cellular detoxification. Research into PEX26 has gained momentum due to its critical role in various human diseases, including peroxisome biogenesis disorders (PBDs) and metabolic syndromes. Understanding PEX26 is imperative, as mutations in the PEX26 gene can lead to impaired peroxisome function, resulting in severe physiological disorders. Recent studies have focused on the structural and functional characterization of PEX26, revealing its interactions with other peroxins and involvement in the import of matrix proteins into peroxisomes. Additionally, the development of recombinant PEX26 proteins has provided valuable tools for in vitro studies, enabling researchers to investigate the mechanism of peroxisome assembly and its regulation. This ongoing research not only aids in elucidating the pathophysiological roles of PEX26 but also holds potential for therapeutic interventions in diseases linked to peroxisomal dysfunction.
